AZ 242, a novel PPARα/γ agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats

Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome

Bo Isomaa, Peter Almgren, Björn Forsén et al. · Diabetes Care · 2001 · 4.8K citations · Full text

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Hanna E. Bloomfield, Sander J. Robins, Dorothea Collins et al. · New England Journal of Medicine · 1999 · 3.4K citations · Full text

Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting

Sander Kersten, Josiane Seydoux, Jeffrey M. Peters et al. · Journal of Clinical Investigation · 1999 · 1.6K citations · Full text

PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

Giulia Chinetti, Sophie Lestavel, Virginie Bocher et al. · Nature Medicine · 2001 · 1.2K citations

Inflammation, Molecular Physiology, Signal Transduction +14

Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study

The Lancet · 2001 · 765 citations